Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT
· Real-Time Price · USD
7.68
-0.99 (-11.42%)
At close: Aug 15, 2025, 3:59 PM
7.83
1.95%
After-hours: Aug 15, 2025, 07:47 PM EDT
Sagimet Biosciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Mar 31, 2021 |
Net Income | -59.38M | -57.11M | -45.57M | -37.52M | -29.25M | -27.92M | -27.88M | -26.92M | -28.03M | -28.35M | -30.5M | -23.3M | -21.39M | -14.28M | -9.53M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | 35K | 69K | 103K | 103K | 68K | 34K | 32K | 32K | 65K | 65K | 33K |
Stock-Based Compensation | 6.15M | 6M | 5.29M | 5.07M | 5.37M | 4.98M | 4.99M | 4.4M | 2.93M | 2.26M | 1.88M | 1.16M | 1.5M | 1.12M | 1.06M |
Other Working Capital | 2.73M | 4.33M | 5.66M | 2.16M | 2.38M | 1.28M | 611K | 967K | 225K | -270K | 3.46M | 3.38M | 2.67M | 2.79M | -868K |
Other Non-Cash Items | -3.6M | -2.77M | -5.82M | -5.76M | 525K | -95K | 63K | -24K | -76K | -114K | -85K | -35K | 805K | 814K | 816K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 2.61M | 3.12M | 3.66M | -280K | 513K | 106K | -978K | -1.63M | -1.31M | -704K | 4.21M | 5.14M | 3.38M | 2.79M | 153K |
Operating Cash Flow | -54.23M | -50.76M | -42.44M | -38.49M | -22.8M | -22.89M | -23.77M | -24.14M | -26.49M | -26.91M | -24.49M | -17.04M | -15.71M | -9.57M | -7.5M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -166.62M | -206.61M | -191.04M | -196.9M | -102.57M | -19.62M | -19.62M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 84.26M | 62.39M | 46.4M | 22.8M | 10.79M | 15.8M | 32.2M | 37.64M | 41.64M | 28.84M | 9.44M | 4M | n/a | n/a | n/a |
Other Investing Acitivies | 82.95M | 82.95M | 82.95M | 82.95M | n/a | 12.8M | 32.2M | 37.64M | 41.64M | -12.61M | -32.01M | -37.45M | -41.45M | n/a | n/a |
Investing Cash Flow | 597K | -61.27M | -61.68M | -91.15M | -91.78M | -3.82M | 12.58M | 37.64M | 41.64M | -12.61M | -32.01M | -37.45M | -41.45M | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 105.75M | 105.72M | 104.82M | -931K | 121K | -762K | 6K | -49K | -1.1M | -221K | -73K | -18K | 130K | 160K | 148K |
Financial Cash Flow | 1K | -27K | 104.82M | 108.34M | 195.55M | 194.67M | 89.69M | 86.11M | -1.1M | -221K | -73K | -18K | 11.13M | 11.16M | 11.14M |
Net Cash Flow | -53.63M | -112.06M | 701K | -24.83M | 77.45M | 164.44M | 74.98M | 99.61M | 14.04M | -39.74M | -56.57M | -54.5M | -46.02M | 1.59M | 3.64M |
Free Cash Flow | -54.23M | -50.76M | -42.44M | -38.49M | -22.8M | -22.89M | -23.77M | -24.14M | -26.49M | -26.91M | -24.49M | -17.04M | -15.71M | -9.57M | -7.5M |